Condition
Premenstrual Dysphoric Disorder (PMDD)
Premenstrual dysphoric disorder is a severe form of premenstrual syndrome in which the body seems unusually sensitive to normal hormone shifts, bringing mood swings, irritability and physical discomfort before a period. The evidence is strongest for calcium, where trials found mood and physical symptoms eased, with vitamin B6 and vitex backed by moderate evidence. For depression symptoms specifically, though, inositol showed no clear difference across five small studies.
Sources: PMID 9731851
- Supplements studied
- 3
- Graded outcomes
- 2
- Trials
- 4
- People studied
- 129
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 41 people | |||
| PMS Symptoms | Improves (the measure goes down) | 9 studies | 41 people | |||
Studies that measured pms symptoms
| ||||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms No effect | NoneNo effect | 5 studies | 71 people | |||
Studies that measured depression symptoms | ||||||
| PMS Symptoms | Improves (the measure goes down) | 1 study | 82 people | |||
Studies that measured pms symptoms | ||||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| PMS Symptoms | Improves (the measure goes down) | 1 study | 6 people | |||
Studies that measured pms symptoms | ||||||
Key findings
- Depression SymptomsImproves (the measure goes down)
The Premenstrual Dysphoric Disorder (PMDD) Supportive Care protocol
2 primary supplements · 7 supporting supplements
- Calcium1,000–1,200 mg daily in divided doses
- Vitamin B650–100 mg daily (do not exceed 100 mg long-term)
Shop the evidence-backed picks
Fullscript collectionWomen's health: evidence-graded picksOpen on Fullscript
The collection holds the supplements we grade A or B for its theme, in products from the Fullscript catalog. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
100 studies from PubMed
- Effects of acute chromium supplementation on postprandial metabolism in healthy young men
- The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects
- Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men
- Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS)
- Efficacy and safety of Vitex agnus-castus extract for treatment of premenstrual syndrome in Japanese patients: a prospective, open-label study
- Dose-dependent efficacy of the Vitex agnus castus extract Ze 440 in patients suffering from premenstrual syndrome
- Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation
- Evaluating therapeutic effect in symptoms of moderate-to-severe premenstrual syndrome with Vitex agnus castus (BNO 1095) in Chinese women
- Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome
- Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder
- Treatment for premenstrual syndrome with Vitex agnus castus: A prospective, randomized, multi-center placebo controlled study in China
- Effects of Vitex agnus and Flaxseed on cyclic mastalgia: A randomized controlled trial
- Effects of chromium supplementation on glycogen synthesis after high-intensity exercise
- Effects of short-term chromium supplementation on insulin sensitivity and body composition in overweight children: randomized, double-blind, placebo-controlled study
- Chromium picolinate supplementation in women: effects on body weight, composition, and iron status
- Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women
- A pilot study of chromium picolinate for weight loss
- Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis
- The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial
- Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome
- The effect of chromium intake on oxidative stress parameters: A systematic review and meta-analysis.
- Effect of chromium supplementation on hs-CRP, TNF-α and IL-6 as risk factor for cardiovascular diseases: A meta-analysis of randomized-controlled trials.
- Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
- Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes
- Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial
- Effects of chromium brewer's yeast supplementation on body mass, blood carbohydrates, and lipids and minerals in type 2 diabetic patients
- The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
- Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus
- Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance
- Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus
- Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus
- Role of chromium supplementation in Indians with type 2 diabetes mellitus
- Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial
- Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus
- Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
- Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes
- The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes
- Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-analysis
- Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study
- Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus
- Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects
- Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women
- The effect of chromium picolinate on muscular strength and body composition in women athletes
- Effects of chromium and resistive training on muscle strength and body composition
- Chromium picolinate effects on body composition and muscular performance in wrestlers
- The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women
- Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study
- Lack of effect of chromium supplementation on mental state and body weight in people with schizophrenia
- Effects of carbohydrate and chromium ingestion during intermittent high-intensity exercise to fatigue
- A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder
- Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil
- Chromium picolinate supplementation for overweight or obese adults
- In patients with HIV-infection, chromium supplementation improves insulin resistance and other metabolic abnormalities: a randomized, double-blind, placebo controlled trial
- Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study
- Effects of chromium picolinate on food intake and satiety
- Chromium supplementation for menstrual cycle-related mood symptoms
- A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving
- Effectiveness of chromium in atypical depression: a placebo-controlled trial
- Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults
- Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus
- Improved cognitive-cerebral function in older adults with chromium supplementation
- Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients
- Effects of Chromium Supplementation on Lipid Profile: an Umbrella of Systematic Review and Meta-analysis.
- A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study
- Resistive training and chromium picolinate: effects on inositols and liver and kidney functions in older adults
- The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
- Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial
- Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients
- Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome
- Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial
- Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
- Pharmacological and Non-Pharmacological Interventions for Polycystic Ovary Syndrome (PCOS) in Indian Women: A Systematic Review and Meta-Analysis.
- Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
- Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
- Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial
- Myo-inositol may prevent gestational diabetes in PCOS women
- Inositol for subfertile women with polycystic ovary syndrome.
- Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome
- One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome
- A phase I study of myo-inositol for lung cancer chemoprevention
- Treatment of hirsutism with myo-inositol: a prospective clinical study
- Inositol for depressive disorders.
- Double-blind, controlled trial of inositol treatment of depression
- Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone
- Inositol addition does not improve depression in SSRI treatment failures
- Effect of inositol on bulimia nervosa and binge eating
- Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
- Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial
- Lack of effect of inositol treatment in chronic schizophrenia
- CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia
- Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder
- Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
- Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder
- Myo-inositol in the treatment of premenstrual dysphoric disorder